Clinical Trial Results:
A multinational, multicenter, randomized, double-blind,
double-dummy, stratified, active controlled parallel group
study comparing the efficacy and safety of intravenous
zoledronic acid, 5 mg once yearly, and oral risedronate, 5
mg daily, in the prevention and treatment of corticosteroid
induced osteoporosis
Summary
|
|
EudraCT number |
2004-000248-25 |
Trial protocol |
HU CZ ES |
Global completion date |
04 Apr 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Jan 2017
|
First version publication date |
02 Jan 2017
|
Other versions |
|
Summary report(s) |
CZOL446O2306 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.